A detailed history of Canaan Partners Xi LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Canaan Partners Xi LLC holds 4,409,991 shares of TYRA stock, worth $87.7 Million. This represents 97.89% of its overall portfolio holdings.

Number of Shares
4,409,991
Previous 4,409,991 -0.0%
Holding current value
$87.7 Million
Previous $70.5 Million 47.03%
% of portfolio
97.89%
Previous 85.38%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

BUY
$12.23 - $31.35 $53.9 Million - $138 Million
4,409,991 New
4,409,991 $62 Million

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $835M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Canaan Partners Xi LLC Portfolio

Follow Canaan Partners Xi LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canaan Partners Xi LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canaan Partners Xi LLC with notifications on news.